Evidence map›Paper›PMID 33897209›Full record

ArticleEthiopian journal of health sciences2020

Functional Haplotypes in the

Shaviya Nathan, Budambula Valentine, Were Tom

Open access · diamondAbstract read
In one paragraph

Article in Ethiopian journal of health sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. rs1445776009 variants in the humanInternational journal of health sciences
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shaviya NathanDepartment of Medical Laboratory Sciences, Masinde Muliro University of Science and Technology, Kakamega, Kenya.
Budambula ValentineDepartment of Environmental Health, Technical University of Mombasa, Kenya.
Were TomDepartment of Medical Laboratory Sciences, Masinde Muliro University of Science and Technology, Kakamega, Kenya.
Masinde Muliro University of Science and Technology · KETechnical University of Mombasa · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman immunodeficiency virus and injection substance use have an influence on genes and gene expression. These effects could be beneficial or detrimental in defining disease outcomes. Adiponectin gene is key in modulating metabolic and immunoregulatory functions. Understanding the effects of human immunodeficiency virus and injection substance use on the gene in the context of antiretroviral therapy is important for predicting disease outcomes.

methodsThis cross-sectional genetic study determined polymorphisms in the promoter region of adiponectin gene. Two variants were analyzed: rs2241766 and rs266729. Polymorphisms were associated with clinical markers of disease outcome; underweight, immunosuppression and viral suppression. The variants were genotyped via random fragment length polymorphism.

resultGC haplotype was associated with higher odds of having underweight (OR, 2.21; 95% CI, 1.83-4.60; P=0.008

conclusionThe study revealed haplotypes of adiponectin gene at loci rs2241766 and rs266729 that could determine disease outcomes in human immunodeficiency virus -1 antiretroviral treatment- naive and experienced injection substance users.

Indexed as

AdiponectinHIV-1HIV InfectionsSubstance Abuse, IntravenousThinnessCross-Sectional StudiesFemaleGenetic Predisposition to DiseaseHaplotypesHumansImmunosuppression TherapyKenyaMalePolymorphism, Single NucleotideAdiponectinADIPOQ protein, humanADIPOQ geneHaplotypesInjection substance use

Identifiers

PMID33897209
PMCPMC8054454
OpenAlexW3087486673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.